Featured
-
-
Article
| Open Access
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
- Yiming Qi
- , Jing Li
- & Cheng Jiang
-
Article
| Open Access
MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma
- Peiluo Huang
- , Hongtao Zhao
- & Juan Du
-
Article
| Open Access
A distributed feature selection pipeline for survival analysis using radiomics in non-small cell lung cancer patients
- Benedetta Gottardelli
- , Varsha Gouthamchand
- & Andrea Damiani
-
Article
| Open Access
Background and clinical significance of biomarker-based patient enrichment in non-small-cell lung cancer drug development
- Kenji Harada
- & Shunsuke Ono
-
Article
| Open Access
Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images
- Leander van Eekelen
- , Joey Spronck
- & Francesco Ciompi
-
Article
| Open Access
Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity
- Andrei Puiu
- , Carlos Gómez Tapia
- & Matthias Siebert
-
Article
| Open Access
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
- Silvia La Monica
- , Federica Vacondio
- & Roberta Alfieri
-
Article
| Open Access
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
- Piyada Sitthideatphaiboon
- , Chonnipa Nantavithya
- & Virote Sriuranpong
-
Article
| Open Access
A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
- Zipei Song
- , Xincen Cao
- & Liang Chen
-
Article
| Open Access
PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT/MAPK signaling
- He Xiu-Ying
- , Zheng Yue-Xiang
- & Wang Ting-Hua
-
Article
| Open Access
Effects of different KRAS mutants and Ki67 expression on diagnosis and prognosis in lung adenocarcinoma
- Jun Wang
- , Liwen Dong
- & Pan Li
-
Article
| Open Access
Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo
- Jing Li
- , Xianmei Zhong
- & Chalermchai Pilapong
-
Article
| Open Access
On chip synthesis of a pH sensitive gefitinib anticancer drug nanocarrier based on chitosan/alginate natural polymers
- Hossein Alizadeh
- , Mazaher Ahmadi
- & Omid Heydari Shayesteh
-
Article
| Open Access
Paclitaxel-induced inhibition of NSCLC invasion and migration via RBFOX3-mediated circIGF1R biogenesis
- Zhanyu Xu
- , Liping Zheng
- & Shikang Li
-
Article
| Open Access
Nurse navigation, symptom monitoring and exercise in vulnerable patients with lung cancer: feasibility of the NAVIGATE intervention
- Rikke Langballe
- , Lukas Svendsen
- & Pernille Envold Bidstrup
-
Article
| Open Access
Assessment of interobserver concordance in radiomic tools for lung nodule classification, with a focus on BRODERS and SILA
- Faysal Al-Ghoula
- , Khushbu Patel
- & Tobias Peikert
-
Article
| Open Access
Influenza activity and regional mortality for non-small cell lung cancer
- Connor J. Kinslow
- , Yuankun Wang
- & Simon K. Cheng
-
Article
| Open Access
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment
- Rodrigo de Oliveira Cavagna
- , Edilene Santos de Andrade
- & Rui Manuel Reis
-
Article
| Open Access
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
- Rita Chiari
- , Silvia Palladino
- & Annamaria Ruzzo
-
Article
| Open Access
Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer
- Kai Tan
- , Changhui Zhang
- & Puhua Zeng
-
Article
| Open Access
Identification of endoplasmic reticulum stress-related signature characterizes the tumor microenvironment and predicts prognosis in lung adenocarcinoma
- Li Wan
- , Zhike Chen
- & Xueping Zhao
-
Article
| Open Access
Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
- Qianjun Zhu
- , Yanfei Chai
- & Wei Feng
-
Article
| Open Access
Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
- Hwa Kyung Park
- , Chang-Seok Yoon
- & Cheol-Kyu Park
-
Article
| Open Access
Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness
- Georgii Vasiukov
- , Yong Zou
- & Pierre P. Massion
-
Article
| Open Access
CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules
- Sijie Feng
- , Shuai Yuan
- & Yunkun Lu
-
Article
| Open Access
Autoencoder-based multimodal prediction of non-small cell lung cancer survival
- Jacob G. Ellen
- , Etai Jacob
- & Natasha Markuzon
-
Article
| Open Access
Detection method has independent prognostic significance in the PLCO lung screening trial
- James P. Long
- & Yu Shen
-
Article
| Open Access
Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
- Woo Kyung Ryu
- , Hyung Keun Cha
- & Jun Hyeok Lim
-
Article
| Open Access
A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70
- Hangeul Park
- , Hyun-Tai Chung
- & Eun Jung Lee
-
Article
| Open Access
Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
- Pauline Gilson
- , Celso Pouget
- & Alexandre Harlé
-
Article
| Open Access
Mathematical model combined with microdosimetric kinetic model for tumor volume calculation in stereotactic body radiation therapy
- Hisashi Nakano
- , Takehiro Shiinoki
- & Hiroyuki Ishikawa
-
Article
| Open Access
Mechanisms of synergistic suppression of ALK-positive lung cancer cell growth by the combination of ALK and SHP2 inhibitors
- M. A. Berry
- , A. R. Bland
- & J. C. Ashton
-
Article
| Open Access
A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma
- Zi Chen
- , Linyang Ge
- & Linfu Zhou
-
Article
| Open Access
Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
- Yaniss Belaroussi
- , Fanny Bouteiller
- & Sophie Cousin
-
Article
| Open Access
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
- Mafalda Antunes-Ferreira
- , Silvia D’Ambrosi
- & Thomas Wurdinger
-
Article
| Open Access
Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
- Mari Tone
- , Kota Iwahori
- & Atsushi Kumanogoh
-
Article
| Open Access
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
- L. Manganaro
- , S. Bianco
- & G.V. Scagliotti
-
Article
| Open Access
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer
- Akira Sakamoto
- , Hiroyuki Inoue
- & Kenzaburo Tani
-
Article
| Open Access
The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
- Lenka Besse
- , Marianne Kraus
- & Ignazio Tarantino
-
Article
| Open Access
Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality
- Ignacio Jusue-Torres
- , Richies Tiv
- & Alicia Hulbert
-
Article
| Open Access
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
- Daichi Fujimoto
- , Satoru Miura
- & Nobuyuki Yamamoto
-
Article
| Open Access
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
- Zakile A. Mfumbilwa
- , Janneke A. Wilschut
- & Veerle M. H. Coupé
-
Article
| Open Access
Pleural fluid microbiota as a biomarker for malignancy and prognosis
- Benjamin Kwok
- , Benjamin G. Wu
- & Jun-Chieh J. Tsay
-
Article
| Open Access
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
- Yael Haberman
- , Iris Kamer
- & Jair Bar
-
Article
| Open Access
Relationship between brain metastasis and thyroid transcription factor 1
- Engin Kut
- & Serkan Menekşe
-
Article
| Open Access
Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer
- Yoshihisa Shimada
- , Yujin Kudo
- & Norihiko Ikeda
-
Article
| Open Access
The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study
- Ying-Yuan Chen
- , Po-Lan Su
- & Yau-Lin Tseng
-
Article
| Open Access
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
- F. Polverino
- , D. Mirra
- & B. D’Agostino
-
Article
| Open Access
Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma
- Jun Zhang
- , Lidong Xu
- & Daoyun Zhang
Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy